申请人:ADIR S.A.R.L.
公开号:US04629728A1
公开(公告)日:1986-12-16
Quinoline compounds of the formula: ##STR1## in which: ##STR2## represents a group of the formula: ##STR3## in which: R' is hydrogen or methyl, R and R" which are the same or different, each represents: hydrogen, (C.sub.1 -C.sub.5) alkyl, (C.sub.1 -C.sub.5) acyl haloacyl or aminoacyl, (C.sub.1 -C.sub.3) alkylsulfonyl, or diethylphosphonyl; n is an integer form 1 to 4 inclusive; T is phenyl, halophenyl, trifluoromethylphenyl [(C.sub.1 -C.sub.5) alkyl] phenyl, [(C.sub.1 -C.sub.5) alkoxy] phenyl, or a five or six-membered heterocyclic radical containing one or two atoms selected from nitrogen and sulfur atoms optionally substituted by one or more (C.sub.1 -C.sub.5) alkyl or (C.sub.1 -C.sub.5) alkoxy. These compounds and physiologically tolerable acid addition salts thereof may be used a medicines especially in the treatment of disorders connected with hypoxemia and energetic metabolic insufficiency especially during cerebral aging.
化学式为:##STR1## 的喹啉类化合物:其中:##STR2## 代表公式:##STR3## 其中:R'为氢或甲基,R和R"相同或不同,分别代表:氢,(C.sub.1-C.sub.5)烷基,(C.sub.1-C.sub.5)酰基卤代酰基或氨基酰基,(C.sub.1-C.sub.3)烷基磺酰基或二乙基膦酰基;n是1到4之间的整数;T是苯基,卤代苯基,三氟甲基苯基,[(C.sub.1-C.sub.5)烷基]苯基,[(C.sub.1-C.sub.5)烷氧基]苯基,或含有1或2个从氮和硫原子中选出的原子的五元或六元杂环基,可选择性地被1个或多个(C.sub.1-C.sub.5)烷基或(C.sub.1-C.sub.5)烷氧基取代。这些化合物和生理耐受的酸盐可以用作药物,特别是用于治疗与低氧血症和能量代谢不足有关的疾病,特别是在脑衰老期间。